ACON Aclarion, Inc.
USHealthcareAs of 2026-07-10 16:00
Why ACON matters now
Aclarion, Inc. (ACON) is a US stock in Healthcare. The latest InvestLog snapshot shows $2.84 with -2.27% on the session and $1.5M in market capitalization; recent performance reads 1-month -2.50% and YTD -32.17%.
The latest financial table shown here is Q1 2026, with revenue of $21.1K, net income of $-2.9M, and EPS of $-1.34. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -441.4%.
The latest indexable market news headline is "Aclarion Announces Texas Spine Care Center as New CLARITY Site" from MCAP MediaWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $—; recent insider activity includes Deitsch Stephen filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.34
P/S
21.37
EV/EBITDA
2.22
DCF Value
$20.54
FCF Yield
-441.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
-58.9%
Operating Margin
-10975.1%
Net Margin
-10336.1%
ROE
-54.4%
ROA
-39.0%
ROIC
-43.5%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $21.1K | $-2.9M | $-1.34 |
| Q4 2025 | $18.5K | $-1.9M | $-2.21 |
| FY 2025 | $75.7K | $-7.2M | $-13.61 |
| Q3 2025 | $18.9K | $-1.7M | $-2.93 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
US
Exchange
—
Beta
1.22
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.